Live cell optical sensing for high throughput applications

Advances in Biochemical Engineering/Biotechnology

Volumn 118, Issue , 2010, Pages 153-164

  Fang, Ye ^a  

^a Corning Incorporated ^*  (United States)

Author keywords

Cell signaling; Cell based assay; Dynamic mass redistribution; G protein coupled receptor; High throughput screening; Optical biosensor; Resonant waveguide grating biosensor

Indexed keywords

LIGAND;

ARTICLE; CELL SURVIVAL; CELLS; CYTOLOGY; DRUG EFFECT; GENETIC PROCEDURES; HIGH THROUGHPUT SCREENING; LIGHT RELATED PHENOMENA; METABOLISM; METHODOLOGY;

BIOSENSING TECHNIQUES; CELL SURVIVAL; CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; LIGANDS; OPTICAL PROCESSES;

EID: 77955529295     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2009_4     Document Type: Article

References (40)

1. Fang Y, Frutos AG, Verkleeren R (2008) Label-free cell-based assays for GPCR screening. Combinatorial Chemistry High Throughput Screening 11: 357-369.
2. Galandrin S, Oligny-Longpre G, Bouvier M (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends in Pharmacol Sci 8:423-430.
3. Gribbon P, Sewing A (2003) Fluorescence readouts in HTS: no gain without pain? Drug Discovery Today 8:1035-1043.
4. Balla T, Varnai P (2002) Visualizing cellular phosphoinositide pools with GFP-fused protein modules. Science STKE 125: 13.
5. Cooper MA (2006) Optical biosensors: where next and how soon. Drug Discovery Today 11: 1061-1067.
6. Rich RL, Myszka DG (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem 361:1-6.
7. Fang Y (2006) Label-free cell-based assays with optical biosensors in drug discovery. Assay Drug Dev Technol 4:583-595.
8. Fang Y (2007) Non-invasive optical biosensor for probing cell signaling. Sensors 7: 2316-2329.
9. Fang Y, Li G, Ferrie AM (2007) Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. J Pharmacol Toxicol Methods 55:314-322.
10. Fang Y, Ferrie AM (2008) Label-free optical biosensor for ligand-directed functional selectivity acting on β2 adrenoceptor in living cells. FEBS Lett 582:558-564.
11. Fang Y, Ferrie AM, Fontaine NH, Yuen PK (2005) Characteristics of dynamic mass redistribution of EGF receptor signaling in living cells measured with label free optical biosensors. Anal Chem 77:5720-5725.
12. Fang Y, Li G, Peng J (2005) Optical biosensor provides insights for bradykinin β2 receptor signaling in A431 cells. FEBS Lett 579:6365-6374.
13. Fang Y, Ferrie AM, Fontaine NH, Mauro J, Balakrishnan J (2006) Resonant waveguide grating biosensor for living cell sensing. Biophys J 91: 1925-1940.
14. Tanaka M, Hiragun T, Tsutsui T, Yanase Y, Suzuki H, Hide M (2008) Surface plasmon resonance biosensor detects the downstream events of active PKC b in antigen-stimulated mast cells. Biosens Bioelectron 23:1652-1658.
15. Horath R, Pedersen HC, Skivesen N, Selmeczi D, Larsen NB (2005) Monitoring of living cell attachment and spreading using reverse symmetry waveguide sensing. Appl Phys Lett 86: e071101.
16. Tiefenthaler K, Lukosz W (1989) Sensitivity of grating couplers as integrated-optical chemical sensors. J Opt Soc Am B 6:209-220.
17. Li G, Ferrie AM, Fang Y (2006) Label-free profiling of endogenous G protein-coupled receptors using a cell-based high throughput screening technology. J Assoc Lab Automat 11:181-187.
18. Ritchie RH (1957) Plasma losses by fast electrons in thin films. Phys Rev 106: 874-881.
19. Barer R, Joseph S (1954) Refractometry of living cells. Part I. Basic principles. Quart J Microsc Science 95:399-423.
20. Lee PH, Gao A, van Staden C, Ly J, Salon J, Xu A, Fang Y, Verkleeren R (2008) Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed G protein-coupled receptors. Assay Drug Develop Technol 6:83-94.
21. Schroeder R, Merten N, Mathiesen JM, Martini L, Kruljac-Letunic A, Krop F, Blaukat A, Fang Y, Tran E, Ulven T, Drewke C, Whistler J, Pardo L, Gomeza J, Kostenis E (2009) The C-terminal tail of CRTH2 is a key molecular determinant that constrains G aiand downstream-signaling cascade activation. J Biol Chem. 284:1324-1336.
22. Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295:1711-1715.
23. Kholodenko BN (2003) Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors. J Exper Biol 206:2073-2082.
24. Bonneau R (2008) Learning biological networks: from modules to dynamics. Nat Chem Biol 4:658-664.
25. Morris AJ, Malbon CC (1999) Physiological regulation of G protein-linked signaling. Physiol Rev 79:1373-1430.
26. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK (2006) Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8:1195-1203.
27. Sato TK, Overduin M, Emr SD (2001) Location, location, location: membrane targeting directed by PX domains. Science 294:1881-1885.
28. Marceau F, Regoli D (2004) Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3:845-852.
29. Liebmann C, Graness A, Ludwig B, Adomeit A, Boehmer A, Boehmer F-D, Nürnberg B, Wetzker R (1996) Dual bradykinin β2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a Gs-mediated stimulation of the cyclic AMP pathway. Biochem J 313:109-118.
30. Graness A, Hanke S, Boehmer F-D, Presek P, Liebmann C (2000) Protein-tyrosine-phosphatasemediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem J 347: 441-447.
31. Mailman R. B. (2007) Ligand-selective signaling and high content for GPCR drugs. Trends in Pharmacol Sci 8:390-396.
32. Samama P, Cotecchia S, Costa T, Lefkowitz RJ (1993) A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
33. Hermans E (2003) Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 99:25-44.
34. Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signaling by b-arrestins. Science 308:512-517.
35. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G (2003) b -arrestinmediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 100:11406-11411.
36. Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY (2007) Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J 26:53-64.
37. Nelson CP, Challiss RAJ (2007) "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73: 737-751.
38. Liapakis G, Chan WC, Papadokostaki M, Javitch JA (2004) Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the β2 adrenergic receptor. Mol Pharmacol 65:1181-1190.
39. Swaminath G, Deupi X, Lee TW, Zhu W, Thian FS, Kobilka TS, Kobilka B (2005) Probing the β2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem 280:22165-22171.
40. Tran E, Fang Y (2008) Duplexed label-free G protein-coupled receptor assays for high throughput screening. J Biomol Screening 13:975-985.